Cite
HARVARD Citation
Vesikari, T. et al. (2021). Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial. Lancet infectious diseases. 21 (9), pp. 1271-1281. [Online].